OCUL
Ocular Therapeutix, Inc. · Healthcare
Chief Scientific Officer Jeffrey S. Heier sold $77K of Ocular Therapeutix, Inc.
Sold$76,626
$7.05Price
10,869Shares
−3%Stake
What OCUL did after the filing
- The stock from Wed, Oct 7 open, $7.26
- −10.5%
- S&P 500, same days
- −2.0%
12 of 30 trading days so far, to the Oct 23 close.
Traded Fri, Oct 2. Filed Tue, Oct 6, 4:43 PM ET, after the close. Returns use the Oct 7 open and the Oct 23 close. Not investment advice.